The phrase "and compared the affinity" is correct and usable in written English.
You can use it when discussing the results of a study or analysis that involves measuring or evaluating the strength of a relationship or interaction between two entities.
Example: "The researchers conducted experiments and compared the affinity of the new drug to existing treatments."
Alternatives: "and evaluated the affinity" or "and assessed the affinity".
We measured the dissociation constants of several putative CAP binding sites by EMSA (Electrophoretic Mobility Shift Assay) and compared the affinities to the bioinformatics scores provided by methods like the weight matrix method and QPMEME (Quadratic Programming Method of Energy Matrix Estimation) trained on known binding sites as well as on the new sites from SELEX SAGE data.
In this study, we have measured and compared the binding affinity of VEGF to VEGFR and VEGF to bevacizumab.
For CR3, CR5 and CR8, we compared the affinity of lysine methyl and ethyl esters and found negligible difference in binding affinity, irrespective of the ionic strength or pH used (results not shown).
Commonly used florescent probes include: warfarin, phenylbutazone for site 1; ibuprofen, naproxen for site 2 and digitoxin for site 3. Miklós Poór et al. compared the affinity to HSA between flavonoids and warfarin [145].
In this step, we compared the affinity of antibodies for antigens presented either in solid or liquid phase.
Finally, we evaluated drug binding affinities using Prime/MMGBSA and using these scores we compared the affinities of combination therapies against MDR1.
We compared the affinities of this peptide with the non-phosphorylated version (Atx1_S_ULM_PE) and with the shorter Atx1_pS_ULM peptide.
In this work, we report a novel surface plasmon resonance (SPR) based live-cell biosensing platform to measure and compare the binding affinity of vascular endothelial growth factor (VEGF) to vascular endothelial growth factor receptor (VEGFR) and VEGF to bevacizumab.
Table 1 summarises and compares the binding affinities of various peptides derived from the hTectonin and GBP.
Before characterizing GC transcript responses in TM cells, we deemed it important to directly measure and compare the GR binding affinity for DEX, FA, and TA, and their potency in a GR-mediated transactivation assay.
